Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

U.S. Authorities Investigates AstraZeneca PLC-Reuters


Thursday, 31 Oct 2013 05:35am EDT 

Reuters reported that AstraZeneca PLC is being investigated by U.S. authorities over a clinical trial that was used to win marketing approval for its new heart drug Brilinta. The British drugmaker said on Thursday it had received a civil investigative demand from the U.S. Department of Justice seeking documents and information regarding the so-called PLATO study. 

Company Quote

4449.0
-18.5 -0.41%
12:15pm EDT